Research Design, Biostatistics, and Literature Evaluation
effects. Pharmacoepidemiol Drug Saf. 2003;12(7):551-
558. https://doi.org/10.1002/pds.883
Moodie EE, Stephens DA. Using directed acyclic graphs
to detect limitations of traditional regression in longitu-
dinal studies. Int J Public Health. 2010;55(6):701-703.
https://doi.org/10.1007/s00038-010-0184-x
Mulla SM, Scott IA, Jackevicius CA, You JJ, Guyatt
GH. How to use a noninferiority trial: users’ guides to
https://doi.org/10.1001/2012.jama.11235
Pallmann P, Bedding AW, Choodari-Oskooei B, et al.
Adaptive designs in clinical trials: why use them, and
how to run and report them. BMC Med. 2018;16(1):29.
https://doi.org/10.1186/s12916-018-1017-7
PEPTIC Investigators for the Australian and New
Alberta Health Services Critical Care Strategic Clinical
Network, and the Irish Critical Care Trials Group;
Young PJ, Bagshaw SM, Forbes AB, et al. Effect of
stress ulcer prophylaxis with proton pump inhibitors vs
histamine-2 receptor blockers on in-hospital mortality
among ICU patients receiving invasive mechanical ven-
2020;323(7):616-626.
https://doi.org/10.1001/
jama.2019.22190
Sevransky JE, Checkley W, Martin GS. Critical care
Med.
2010;38(9):1882-1889.
https://doi.org/10.1097/
ccm.0b013e3181eae226
Stanley K. Design of randomized controlled tri-
als. Circulation. 2007;115(9):1164-1169. https://doi.
org/10.1161/circulationaha.105.594945
Stanski NL, Wong HR. Prognostic and predictive
enrichment in sepsis. Nat Rev Nephrol. 2020;16(1):20-
31. https://doi.org/10.1038/s41581-019-0199-3
Suissa S. Effectiveness of inhaled corticosteroids in
chronic obstructive pulmonary disease: immortal
rccm.200210-1231oc
Talisa VB, Yende S, Seymour CW, Angus DC. Arguing
for adaptive clinical trials in sepsis. Front Immunol.
2018;9:1502. https://doi.org/10.3389/fimmu.2018.01502
Statistical Analysis
Gaddis GM, Gaddis ML. Introduction to biosta-
Med.
1990;19(3):309-315.
https://doi.org/10.1016/
s0196-0644(05)82052-9
Gaddis GM, Gaddis ML. Introduction to biostatistics.
Part 3. Sensitivity, specificity, predictive value, and
https://doi.org/10.1016/s0196-0644(05)82198-5
Gaddis GM, Gaddis ML. Introduction to biostatistics.
Part 4. Statistical inference techniques in hypothesis
doi.org/10.1016/s0196-0644(05)81712-3
Gaddis GM, Gaddis ML. Introduction to biostatistics.
Part 5. Statistical inference techniques for hypoth-
Med.
1990;19(9):1054-1059.
https://doi.org/10.1016/
s0196-0644(05)82571-5
Gaddis ML, Gaddis GM. Introduction to biostatistics.
89. https://doi.org/10.1016/s0196-0644(05)82149-3
Gaddis ML, Gaddis GM. Introduction to biostatis-
Med.
1990;19(12):1462-1468.
https://doi.org/10.1016/
s0196-0644(05)82622-8
Guyatt GH; McMaster University. Users’ Guides to
the Medical Literature: A Manual for Evidence-Based
Clinical Practice. 3rd ed. McGraw-Hill Professional;
2015.
Hernández G, Ospina-Tascón GA, Damiani LP, et
al. Effect of a resuscitation strategy targeting periph-
eral perfusion status vs serum lactate levels on 28-day
mortality among patients with septic shock: the
ANDROMEDA-SHOCK randomized clinical trial.
jama.2019.0071
Huang B, Szczesniak R. Can’t see the wood for the trees:
confounders, colliders and causal inference—a statisti-
cian’s approach. Thorax. 2019;74(4):323-325. https://doi.
org/10.1136/thoraxjnl-2018-212780
Kier KL. Biostatistical applications in epidemiol-
org/10.1592/phco.31.1.9
Lederer DJ, Bell SC, Branson RD, et al. Control of con-
founding and reporting of results in causal inference